Key result
R-CHOP therapy stabilized the clinical state of a 62-year-old male with primary cardiac lymphoma presenting with syncope and cardiac tamponade at 3 months follow-up.
Why the study?
Primary cardiac lymphoma is extremely rare with poor prognosis, typically presenting with heart failure, pericardial effusion, tamponade, or arrhythmias.
Population
A 62-year-old male with primary cardiac lymphoma presenting with syncope and cardiac tamponade
Comparison
R-CHOP therapy after failure of surgery
Design
Case report
Follow-up
3 months
Authors
Loading...
May support R-CHOP in rare primary cardiac lymphoma with tamponade; hypothesis-generating from single case report.
Case Report (n=1)
Highlights a rare case of primary cardiac lymphoma presenting with syncope and cardiac tamponade, successfully stabilized with R-CHOP therapy after surgical failure.
Serra et al. (2021) conducted a case report in Primary cardiac lymphoma (n=1). R-CHOP therapy was evaluated on Clinical state. R-CHOP therapy stabilized the clinical state of a 62-year-old male with primary cardiac lymphoma presenting with syncope and cardiac tamponade at 3 months follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: